Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Commentary on COVID-19-induced liver injury in various age and risk groups
Öner Özdemir, Hacer Efnan Melek Arsoy, Department of Pediatrics, Sakarya University, Medical Faculty, Sakarya 54100, Türkiye
Author contributions: Özdemir Ö and HE Melek Arsoy wrote the mini-review.
Conflict-of-interest statement: All the authors declare that they have no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Öner Özdemir, MD, Professor, Department of Pediatrics, Sakarya University, Medical Faculty, Şirinevler Mahallesi Adnan Menderes Caddesi No. 193 Adapazarı, Sakarya 54100, Türkiye. ozdemir_oner@hotmail.com
Received: September 25, 2022
Peer-review started: September 25, 2022
First decision: November 5, 2022
Revised: November 15, 2022
Accepted: December 21, 2022
Article in press: December 21, 2022
Published online: January 25, 2023
Peer-review started: September 25, 2022
First decision: November 5, 2022
Revised: November 15, 2022
Accepted: December 21, 2022
Article in press: December 21, 2022
Published online: January 25, 2023
Core Tip
Core Tip: Coronavirus disease 2019 (COVID-19) can progress primarily with symptoms ranging from a mild upper respiratory tract infection to severe pneumonia, hepatic injury, and even death. There is currently increasing interest in COVID-19 interaction with liver tissue. We would like to discuss the details of liver injury/dysfunction in COVID-19 in the current literature.